Manchester Management PR, LLC

Manchester Management PR, LLC is a declared insider at 2 companies; the most frequent names are Fennec Pharmaceuticals Inc. and SideChannel, Inc. In total, 122 filings cover trades dated from 27 January 2016 to 30 September 2019.

On the open market, the record shows 91 purchases worth €1.3M and 31 sales worth €8.4M. Sales outweigh purchases by €7.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2019 alone, the filings show 5 purchases and no sales.

The median purchase comes to €5,558. The 9 purchases reviewed show no overlap with other insiders buying the same stock within a month. Ninety days after publication, 12 purchases show a median change of -23.6%, with the price up in 17% of them. These figures describe past trades and do not predict future prices.

On 3 October 2019 came the latest disclosure, an open-market purchase for €5,252 in SideChannel, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.